Related Experiment Video
Updated: Jul 5, 2026
05:57
Fission Yeast as a Platform for Antibacterial Drug Screens Targeting Bacterial Cytoskeleton Proteins
Published on: April 26, 2024
The hydrogenosome as a drug target
1Universidade Santa Ursula, Laboratório de Ultraestrutura Celular, Rio de Janeiro, Brazil. marleneben@uol.com.br
Current Pharmaceutical Design
|May 14, 2008
Summary
Hydrogenosomes, organelles in some organisms, share similarities with mitochondria but lack genetic material and a respiratory chain. Their unique metabolic pathways make them ideal drug targets for treating infections like trichomoniasis.
Area of Science:
- Cell Biology
- Parasitology
- Biochemistry
Background:
- Hydrogenosomes are unique organelles found in anaerobic eukaryotes, notably in *Trichomonas*.
- They share structural and functional similarities with mitochondria, including ATP production and protein import.
- Key differences include the absence of genetic material, respiratory chain, and oxidative phosphorylation in *Trichomonas* hydrogenosomes.
Purpose of the Study:
- To compare hydrogenosomes with mitochondria.
- To highlight the distinct metabolic pathways of hydrogenosomes.
- To underscore the potential of hydrogenosomes as drug targets.
Main Methods:
- Comparative analysis of organelle structure and function.
- Review of existing literature on hydrogenosome biology and drug interactions.
- Observation of cellular and organelle morphology under various drug treatments.
Main Results:
- Hydrogenosomes possess distinct biochemical pathways compared to mitochondria.
- Drug treatments targeting hydrogenosomes induce morphological changes and dysfunction.
- Metronidazole is a primary drug effective against trichomonads by targeting hydrogenosomes.
Conclusions:
- Hydrogenosomes represent a viable and specific drug target due to their unique metabolic processes.
- Targeting hydrogenosomes offers a strategy to develop new antiparasitic agents with minimal host cell toxicity.
- Further research into hydrogenosome-specific pathways can lead to novel therapeutic interventions.
Related Concept Videos
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
02:17Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
Catalytic hydrogenation of alkenes is a transition-metal catalyzed reduction of the double bond using molecular hydrogen to give alkanes. The mode of hydrogen addition follows syn stereochemistry.
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
00:26Hydrogen Bonds
Hydrogen BondsHydrogen bonds are weak attractions between atoms that have formed other chemical bonds. One of these atoms is electronegative, like oxygen, and has a partial negative charge. The other is a hydrogen atom that has bonded with another electronegative atom and has a partial positive charge.Hydrogen Bonds Control the World!Because hydrogen has very weak electronegativity when it binds with a strongly electronegative atom, such as oxygen or nitrogen, electrons in the bond are...
01:16Drug Biotransformation: Overview
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...